Trial intelligence / Profile preview

Nitroglycerin Hydrogel for Critical Bone Defects

NCT06925763Not yet recruiting

Sponsor
Minia University
Start
Apr 2025
Primary completion
Apr 2025
Modality
Small Molecules
Countries
1
01

Overview

Randomised trial of nitroglycerin in Bone defect (3 arms), sponsored by Minia University. Primary endpoint: Radiographic analysis of bone regeneration at 2 months. Planned start Apr 2025; status: not yet recruiting.

02

Drugs

nitroglycerin
03

Conditions

Bone defect

Beyond the preview

Go deeper on NCT06925763.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06925763.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call